Justine A. Vionnet

Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues.

E. Reed, M. Dabholkar, J. Vionnet, 2000, Biochemical pharmacology.

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies.

R. Tarone, E. Reed, F. Muggia, 1993, Cancer research.